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Objectives: To examine if exercise referral schemes (ERS)s are associated with meaningful changes 
in health and wellbeing in a large cohort of individuals throughout England, Scotland, and Wales from 
The National Referral Database. 
Methods: Data were obtained from 23,731 participants from 13 different ERSs lasting 6 weeks to 3 
months. Changes from pre- to post-ERS in health and wellbeing outcomes were examined including 
body mass index (BMI), blood pressure (SBP & DBP), resting heart rate (RHR), short Warwick 
Edinburgh Mental Wellbeing Scale (SWEMWBS), World Health Organization Well-Being Index 
(WHO-5), Exercise Related Quality of Life scale (ERQoL), and Exercise Self-Efficacy Scale (ESES). 
Two-stage individual patient data meta-analysis was used to generate effect estimates.  
Results: Estimates [95%CIs] revealed statistically significant changes occurred compared to point 
nulls for BMI (-0.55 kg.m
2
 [-0.69 to -0.41]), SBP (-2.95 mmHg [-3.97 to -1.92]), SWEMWBS (2.99 
pts [1.61 to 4.36]), WHO-5 (8.78 pts [6.84 to 10.63]), ERQoL (15.26 pts [4.71 to 25.82]), ESES (2.58 
pts [1.76 to 3.40]), but not RHR (0.22 fc [-1.57 to 1.12]), DBP (-0.93 mmHg [-1.51 to -0.35]). 
However, comparisons of estimates [95%CIs] against null intervals suggested the majority of 
outcomes may not improve meaningfully.  
Conclusions: We considered whether meaningful health and wellbeing changes occur in people who 
are undergoing ERSs? Regarding this broad question, these results demonstrate that, although many 
health and wellbeing outcomes improved, the changes be not achieve meaningful levels. This suggests 







What is already known on this topic? 
 Physical activity is widely considered to be effective in the prevention, management, and 
treatment of many chronic health disorders, yet population physical activity levels are 
relatively low and have changed little in recent years. 
 Sufficient physical activity levels for health and wellbeing often do not arise as result of 
typical activities of daily living and thus, specific exercise has been argued to be necessary for 
many, and one approach to providing this has been through exercise referral schemes.  
 These are aimed at increasing physical activity levels in sedentary individuals with chronic 
disease, however, evidence is currently lacking as to whether exercise referral schemes are 
effective as currently implemented. 
 
What this study adds 
 Our findings suggest that, though exercise referral schemes are associated with statistically 
significant changes in most health and wellbeing outcomes, the size of the changes was not as 
clinically meaningful as would be hoped for.  
 These findings support the need to consider exercise referral schemes, and particularly their 
implementation, more critically using real world data to understand how best to maximise 
their potential, particularly considering the known benefits of exercise, and the reach of ERSs 








 Engagement in physical activity is widely considered to be effective in the prevention, 
management, and treatment of many chronic health disorders.[1,2] Despite this, in the United 
Kingdom (UK) a recent survey has shown that population levels of physical activity have remained 
unchanged in recent years, with a large proportion of the population still classed as inactive presenting 
potentially serious repercussions for population health.[3] The costs of physical inactivity to the 
National Health Service (NHS) were estimated as £900 million in 2015 [4] which, despite relatively 
stable levels of physical activity, had risen to £1.2 billion in 2017.[5] Though it is hoped that 
population wide increases in physical activity are possible they are difficult to achieve and thought to 
require complex interventions aimed at several socio-ecological levels.[6-9] Therefore it has been 
argued that the promotion of physical activity must be a key component of a healthcare system within 
a ‘whole systems approach’.[10]  
 For many, achievement of sufficient levels of physical activity evidently does not arise from 
their typical activities of daily living in our present socio-ecological environment. Instead, as 
opportunities for spontaneous physical activity during daily life have likely reduced in our modern 
environment despite our bodies still ‘expecting’ this stimulus, directed exercise [11]a may be a 
necessity for health and fitness in this current era.[1]  Indeed, compared with replacing sedentary 
activity with just light physical activity, structured exercise may have differential effect health 
effects.[12] Further, for many conditions, network meta-analyses have shown exercise interventions 
are similarly, and in some cases more, effective than drug treatments for secondary prevention.[13,14] 
In this respect, it has been argued that exercise should perhaps be prescribed to patients much like a 
drug,[15] and as noted may be similarly effective.[12] Further, for some, recommendation from a 
                                                          
a
 It is worth differentiating physical activity from exercise here. Physical activity has been adopted as a term for 
those activities which are unstructured and occur as a result of tasks of daily living, occupation, or leisure 
without the explicit goal of improved health and/or fitness whereas exercise, though falling under the broad 
category of physical activity, involves tasks often specifically engaged in for the pursuit of improved health 
and/or fitness.[11]  Both may present potential disturbances to homeostasis as a result of muscular action thus 
providing stimulus for adaptation including improved health and fitness.[11] 
physician/general practitioner (GP) may be a key facilitator in participating in exercise in the first 
place.[16]  
 Considering a ‘whole systems approach’, where physical activity is argued to be a key 
component,[10] management and treatment of chronic diseases with exercise has been built into 
public health pathways and healthcare models through the use of exercise referral schemes (ERS). In 
ERS primary care professional, most commonly a GP, will refer a patient with, or at risk of, a chronic 
health disorder, into an exercise based intervention.[17,18] ERS were first introduced in the 1990s in 
primary care settings to facilitate exercise participation in those suffering from chronic disease.[19,20] 
Delivery of ERS usually occurs through leisure/sport centre pathways and often includes both 
cardiorespiratory and resistance training modalities, though despite typically poor reporting of the 
specific exercise intervention employed there is likely considerable heterogeneity in programme 
implementation.[17,18] ERS typically last from 10-12 weeks in England and Ireland,[18] or 16 weeks 
in Wales, the latter of which has been shown as more cost effective.[21]  
Considering the current issues with the extant literature regarding ERS including inconsistent 
and weak evidence regarding their effects upon health, wellbeing, and quality of life outcomes 
[17,18,22,23] there is a need for continued evaluation to help inform guidelines regarding 
them.[17,24] Recent updated systematic review has highlighted that ERSs in the UK may be effective 
and that longer schemes may be more so than shorter schemes.[25] However, most schemes focus 
upon physical activity changes solely likely considering them appropriate surrogates for improved 
health and wellbeing. As such, it has been argued that ERS, and evaluation of their benefits, should 
extend beyond merely increasing physical activity levels and consider other health and wellbeing 
outcomes.[26]  Thus the aim of this paper is to describe the initial insights obtained from individual 
patient data meta-analysis of The National Referral Database [27] with a primary focus on the effects 
(i.e. change from pre- to post-ERS), including point estimates and precision of those estimates, of 






An accompanying pre-print manuscript [27] describes the database formation, data cleaning, 
and structure in detail in addition to the key issues and limitations of the database. For sake of space 
this is not replicated here but the reader is encouraged to refer to this pre-print [27] to interpret the 
findings presented in their appropriate context. In essence, this database represents a retrospective 
cohort longitudinal study design following individuals entering and exiting ERS following referral 
from a range of organisations and referrer types (primary, secondary, and tertiary) across the UK. The 
database includes ERSs broadly speaking and unfortunately at present data is unavailable regarding 
their specific delivery, though work is underway to retrospectively determine details of this 
conforming to current reporting standards and described in Steele et al.[27] Due to the inclusion of 
different schemes within the database with varying and unspecified characteristics we used individual 
patient data meta-analysis with a two stage approach to account for this in analysis in providing point 
estimates and precision. 
 
Outcome Measures 
Outcome measures varied across the ERS but were taken at both pre- and post-intervention 
across all ERS. The majority of schemes included height and weight and from this body mass index 
(BMI) could be calculated. Blood pressure,[28] systolic (SBP) and diastolic (DBP), and resting heart 
rate were also included as outcomes in the majority of schemes. Mental wellbeing was included and 
measured in a small number of ERS using the short Warwick Edinburgh Mental Wellbeing Scale 
(SWEMWBS) [29] and general wellbeing and quality of life using the World Health Organization 
Well-Being Index (WHO-5),[30] and Exercise Related Quality of Life scale (ERQoL).[31] Lastly, 




Two stage individual patient data meta-analysis was performed on the change scores (i.e. 
post- minus pre-ERS scores) for each outcome measure. For stage one, change scores and their 
standard errors were derived for each scheme. For all measures, change scores were calculated in their 
raw units of measurement. The second stage involved performing a random effects meta-analysis 
using the ‘metafor’ package in R (version 3.5.0; R Core Development Team, https://www.r-
project.org/) across all schemes in order to derive a final point estimate and precision of estimates 
(95% confidence intervals [CI]). Estimates were weighted by inverse sampling variance and restricted 
maximal likelihood estimation was used in all models. Schemes without sufficient participants (n < 4) 
were excluded from analysis in order to maintain sufficient sample sizes for precision of a one sample 
effect estimate calculated at 1 σ unit for the margin of error (or 95% confidence interval half width; 
ESCI 10-13, La Trobe University, Australia). Robustness of main effects were considered through 
sensitivity analyses by removal of individual schemes and re-analysis of the random effects model. 
Where significant estimates became non-significant and vice versa, in addition to where there were 
considerable changes in the magnitude and/or precision of those estimates, the results of sensitivity 
analyses are reported. Although initially intended, the effects of scheme length as a moderator were 
not examined due to the inclusion of only one scheme 6 weeks in length. It was considered that the 
slight difference between 12 weeks and 3 months (6 days) was unlikely to have any meaningful 
impact upon the analysis and any statistically significant findings might arise from type I errors. 
Where it was possible to use an informed null interval, for each outcome measure we also 
calculated second generation p values [33] as supplementary statistics for the point estimate and 
precision of estimate of the random effects meta-analysis. The null interval for changes in each 
outcome were as follows: BMI = -1 to +1 kg.m
2
 [34]; RHR = -5 to +5 fc [35]; SBP & DBP = -2 to +2 
mmHg [28]; WHO-5 = -10 to +10 pts [30]; SWEMWBS = -2.77 to +2.77 pts [36]. These null 
intervals were plotted onto forest plots for visual interpretation. Published data regarding either 
minimal clinically important changes, reliability etc. were not available for ERQoL or ESES and so 
second generation p values were not calculated for these outcomes. 
An α level of 0.05 was used to determine statistical significance, however results were not 
interpreted dichotomously based purely on this, or whether the 95%CIs crossed zero. As noted, 
supplementary statistics in the form of second generation p values (pδ) were also calculated to 
determine the proportion of data supported hypotheses that fall outside the null interval determined by 
the MCICs where a value of 1 suggested the data support only null hypotheses (i.e. no meaningful 
change in outcome), a value of 0 suggests the data support only alternative hypotheses (i.e. a 
meaningful change in outcome), and a value between these suggests the data are inconclusive at this 
stage (i.e. the possibility of both meaningful or non-meaningful changes are supported by the data). In 
essence, pδ described the degree of overlap between the interval estimate (95%CIs) for the changes in 
outcome measures with the null intervals (MCICs) noted above. That is to say the analyses performed 
were with the intention of reporting broadly; do we observe a meaningful effect in people who are 
undergoing ERSs? 
Additional supplemental meta-regression analyses were conducted to examine the association 
between changes in physical activity levels and changes in health and wellbeing outcomes. The results 
of these supplementary analyses are reported in the supplementary materials. 
 
Results 
Table 1 shows the final samples included in analysis. Table 2 shows the pre-ERS scores 
across the schemes for each of the outcome measures examined.
 
Results from the supplementary 
meta-regressions are reported in the accompanying supplementary materials).  
 
Body Mass Index 
For BMI one scheme was excluded due to small sample size (scheme 5028) and a total of 11 
schemes including 4,834 participants were included for analysis. Change in BMI differed significantly 
from the point null of zero (-0.55 kg.m
2
 [-0.69 to -0.41], p < 0.0001). Figure 1 shows the forest plot 
for BMI. Significant heterogeneity was evident among the schemes (Q(10) = 161.34, p < 0.001; I
2
 = 
96.5%), however, sensitivity analysis did not reveal any influential schemes. The second generation p 
value for the estimate from the random effects model meta-analysis was pδ = 1.00 due to the interval 





Resting Heart Rate 
For RHR one scheme was excluded due to small sample size (scheme 5028) and a total of 9 
schemes including 4,287 participants were included for analysis. Change in RHR did not differ 
significantly from the point null of zero (-0.22 fc [-1.57 to 1.12], p = 0.7448). Figure 2 shows the 
forest plot for RHR. Significant heterogeneity was evident among the schemes (Q(8) = 185.46, p < 
0.001; I
2
 = 97.5%), however, sensitivity analysis did not reveal any influential schemes. The second 
generation p value for the estimate from the random effects model meta-analysis was pδ = 1.00 due to 
the interval estimate being entirely within the null interval suggesting that the data supported only null 
hypotheses. 
 
Systolic Blood Pressure 
For SBP two schemes were excluded due to small sample size (schemes 5028 and 5144) and 
a total of 11 schemes including 7,389 participants were included for analysis. Change in SBP differed 
significantly from the point null of zero (-2.95 mmHg [-3.97 to -1.92], p < 0.0001). Figure 3 shows 
the forest plot for SBP. Significant heterogeneity was evident among the schemes (Q(10) = 55.38, p < 
0.001; I
2
 = 89.26%), however, sensitivity analysis did not reveal any influential schemes. The second 
generation p value for the estimate from the random effects model meta-analysis was pδ = 0.039 due 
to the interval estimate being only partly overlapped with the null interval suggesting that the majority 
of data supported hypotheses are that SBP decreases meaningfully, though the data are not wholly 
conclusive. 
 
Diastolic Blood Pressure 
For DBP two schemes were excluded due to small sample size (schemes 5028 and 5144) and 
a total of 11 schemes including 7,451 participants were included for analysis. Change in DBP differed 
significantly from the point null of zero (-0.93 mmHg [-1.51 to -0.35], p = 0.0016). Figure 4 shows 
the forest plot for SBP. Significant heterogeneity was evident among the schemes (Q(10) = 48.25, p < 
0.001; I
2
 = 85.39%), however, sensitivity analysis did not reveal any influential schemes. The second 
generation p value for the estimate from the random effects model meta-analysis was pδ = 1.00 due to 
the interval estimate being entirely within the null interval suggesting that the data supported only null 
hypotheses. 
 
Short Warwick Edinburgh Mental Wellbeing Scale 
A total of 3 schemes including 1,625 participants were included for analysis. Change in 
SWEMWBS differed significantly from the point null of zero (2.99 pts [1.61 to 4.36], p < 0.0001). 
Figure 5 shows the forest plot for SWEMWBS. Significant heterogeneity was evident among the 
schemes (Q(2) = 11.04, p < 0.001; I
2
 = 77.97%). Sensitivity analysis did not reveal any influential 
schemes with respect to altering whether the estimate statistically significantly differed (i.e. shifted 
from significant to non-significant). Removal of scheme 5002 resulted in an increase in estimate to 
3.81 [2.73 to 4.89]. The second generation p value for the estimate from the random effects model 
meta-analysis was pδ = 0.422 due to the interval estimate being overlapped with the null interval 
suggesting that the data are inconclusive. When scheme 5002 was removed this was reduced to pδ = 
0.018 due to the interval estimate being only partly overlapped with the null interval suggesting that 
the majority of data supported hypotheses are that SWEMWBS increases meaningfully, though the 
data are not wholly conclusive. Considering the weighting of scheme 5002 in the random effects 
model meta-analysis it seems more likely that the original estimate and confidence intervals including 
all schemes is a better estimate of the true effect. 
 
World Health Organization Well-being Index 
 Only one scheme (5131) collected the WHO-5 as an outcome measure and included 449 
participants. Point estimate for change in WHO-5 score was 8.78 pts [6.84 to 10.63]. The second 
generation p value for the estimate was pδ = 0.834 due to the interval estimate being only partly 
overlapped with the null interval suggesting that the majority of data supported hypotheses are that 
null, though the data are not wholly conclusive.  
 
Exercise Related Quality of Life scale 
For ERQoL one scheme was excluded due to small sample size (scheme 5119) and a total of 
3 schemes including 777 participants were included for analysis. Change in ERQoL differed 
significantly from the point null of zero (15.26 pts [4.71 to 25.82], p =0.0046). Figure 6 shows the 
forest plot for ERQoL. Significant heterogeneity was evident among the schemes (Q(2) = 254.21, p < 
0.001; I
2
 = 99.1%). Sensitivity analysis did not reveal any influential schemes with respect to altering 
whether the estimate statistically significantly differed (i.e. shifted from significant to non-
significant). However, removal of scheme 5156 resulted in a reduction in the point estimate but an 
increase in the precision (9.83 pts [8.70 to 10.95], p < 0.001). 
 
Exercise Self Efficacy Scale 
 Only one scheme (5131) collected the ESES as an outcome measure and included 252 




 Despite widespread adoption, research exploring the effect of ERSs on health outcomes from 
ecologically valid datasets is scarce. The results presented here describe the initial findings from first 
analysis of the National Referral Database; a UK wide database of ERS based on the Standard 
Evaluation Framework for physical activity interventions. The analyses performed here were with the 
intention of considering broadly; do we observe a meaningful effect in people who are undergoing 
ERSs? The present results demonstrate that, although many health and wellbeing outcome changes 
are statistically significant when compared to point null estimates (i.e. they differ from a change of 
zero) our analysis revealed a general lack of meaningful change over time in participants undergoing 
ERSs lasting between six weeks to three months. 
 For BMI our results suggested that the change over time was statistically significant, 
yet unlikely to be meaningful (-0.55 kg.m
2
 [-0.69 to -0.41], p < 0.0001, pδ = 1.0). This is perhaps 
unsurprising as physical activity or exercise based intervention as standalone approaches seem to lack 
effectiveness for eliciting changes in body mass [37]. Indeed, in their systematic review and meta-
analysis, Pavey et al [18] reported no significant (or meaningful considering the criteria used here) 
differences in their meta-analysis of the effects of ERSs compared with other comparator 
interventions upon BMI. Studies of ERS ranging from eight weeks to four months show similarly 
little changes in BMI (i.e. ranging from no change to ~0.6 kg.m
2
 [22,38-40]). Considering that 
participants undergoing ERSs in our sample were obese (BMI = 31.53±6.53 kg.m
2
) lack of 
effectiveness could be considered an issue particularly as ERSs have been noted as being tied to the 
current ‘obesity agenda’.[41] With the multiple lines of evidence suggesting that, alone, exercise may 
not result in meaningful weight loss, it may be argued that ERSs might benefit from combination with 
dietary guidance. There is perhaps potential here for wider social prescribing efforts regarding 
nutritional knowledge to coordinate with physical activity based interventions such a ERSs. 
Particularly as a BMI classified as overweight or obesity, albeit a crude measure, is on a population 
level associated with all-cause mortality risk.[42] One explanation for the lack of effect observed 
here, could be that positive changes in body composition occurred resulting in similar BMI post ERS 
(decrease in body fat and increase in lean mass). Such results have been shown to occur with a 
supervised resistance training based ERSs [43] and so, despite the lack of meaningful change in BMI, 
participants in the ERSs examined here may have experienced positive changes in body composition. 
Indeed, the supplementary meta-regression performed revealed a significant positive coefficient for 
change in BMI with change in vigorous minutes as a moderator (0.47 kg.m
2
 [0.18 to 0.76], p = 
0.0013; see supplementary materials) whereas this was not the case for total MET-minutes, moderate 
minutes, walking minutes, or sitting minutes. This may reflect positive body composition changes as a 
result of increased vigorous activity. 
 Measures of cardiovascular health, including RHR and blood pressure, were common 
outcomes in many of the ERSs observed here. High RHR is known to be a risk factor for both 
cardiovascular and all-cause mortality [44] yet no change was observed over time in those 
participating in ERSs according to our analysis. Only one paper reporting the results of three small 
studies (n’s ranged from 11 to 65) has reported changes in RHR from ERS and our data is supportive 
of these. Webb et al [40] reported point estimates ranging from +2.0 to -6.8 fc as a result of an eight 
week ERS. Heart rate data from FitBit covering 150 billion hours of activity suggests that in those 
who are 55 years of age (similar to the sample in the current database), an increase of 180 minutes’ 
physical activity is needed to see an improvement in RHR of around ~6.5 fc.[45] Previous meta-
analysis of controlled trials has also shown an average change after endurance training of -6 fc.[46] As 
noted, the exact ‘exercise prescription’ for ERS observed here is unknown and so it is difficult to 
know whether the lack of change in RHR might result from the implementation of exercise 
components that lack efficacy (i.e. either of insufficient volume or intensity of effort), or indeed due 
to poor fidelity of their implementation.  
 The change in SBP reported here was statistically significant, although its clinical 
meaningfulness should be treated with caution (-2.95 mmHg [-3.97 to -1.92], p < 0.0001, pδ = 0.039). 
Recent network meta-analysis shows that structured exercise interventions can produce similar 
reductions in SBP compared with anti-hypertensive medications,[13] though their effect estimates 
were greater than those reported here (-4.84 mmHg [-5.55 to -4.13] across all populations). This may 
be due to interventions being examined in the context of randomized controlled trials as opposed to 
the observational data examined here from ‘real-world’ interventions. Reduction in SBP to a range of 
120 to 124 mmHg may provide the greatest reductions in risk of cardiovascular disease and all-cause 
mortality, particularly if the reduction to this level is large.[47] The mean baseline SBP for 
participants in the database was 131.70±16.91 mmHg and thus considering the results of Bundy et al 
[47] highlighting that large SBP reductions produce the greatest mortality risk reduction,  in 
combination with the small reduction reported here, it is unclear whether sufficient reduction might 
have occurred to have meaningfully reduced risk. Though other studies of ERSs also report reductions 
in SBP these are either similarly small (-2.84 mmHg [-6.57 to 0.82] and -3.53 mmHg [-7.31 to 0.25] 
[22]; -3.2 mmHg [-4.6 to 1.7] and -2.9 mmHg [-4.4 to 1.4] [38]) or variable in their point estimates (-
6.1 to +4.8 mmHg [40]). This is perhaps unsurprising as meta-analysis [48] suggest reductions are 
small for endurance type exercise (-3.5 mmHg [-4.6 to -2.3) and dynamic resistance training (-1.8 
mmHg [-3.7 to -0.011]). The exception to this appears to be isometric exercise which produced far 
larger reductions (-10.9 mmHg [-14.5 to -7.4] [48]) suggesting that this form of exercise should 
perhaps be incorporated into ERSs. Cornelissen and Smart [48] also reported that reductions in blood 
pressure may be greater in prehypertensive or hypertensive participants and so, considering also the 
results of the recent network meta-analysis by Bundy et al,[47] it could be that the typical participant 
referred to an ERS may be unlikely to benefit meaningfully from it.  
 A statistically significant reduction in DBP was observed, yet this was unlikely to be 
clinically meaningful (-0.93 mmHg [-1.51 to -0.35], p = 0.0016, pδ = 1.00). Though as noted, a 
reduction in SBP to a range of 120 to 124 mmHg may reduce cardiovascular and all-cause mortality 
risk,[47] recent evidence also suggests that, when SBP is in the range of 120 to 140 mmHg, a DBP of 
70 to 80 mmHg is optimal for reduced morbidity and mortality risk.[49] Participants in the database 
had baseline DBPs at the high end of the optimal range on average (80.13±9.91 mmHg) and so the 
small reduction found here might be considered meaningful in context; yet, it is unlikely that such a 
dichotomous consideration is accurate. As with SBP, prior studies typically show either no effects, or 
very small and variable effects, upon DBP with ERSs (0.77 mmHg [-2.07,3.61] and 1.55 mmHg [-
1.02,4.11] [22]; -2.5 mmHg [-3.5 to -1.5] and 0.2 mmHg [-3.8 to -0.8] [38]; -4.1 mmHg to 3.0 point 
estimates [40]). Again this is perhaps unsurprising given the small effects reported in meta-analysis 
[48] for endurance exercise (-2.5 mmHg [-3.2 to -1.7]) and dynamic resistance training (-3.2 mmHg [-
4.2 to -2.0]), or combined training (-2.2 mmHg [-3.9 to -0.48]). Though again isometric exercise 
appears more effective than traditional approaches (-6.2 mmHg [-10.30 to -2.0]). Of course as noted, 
we were unable to consider the impact of different exercise approaches used within the ERSs 
examined here so again it may be that the relatively small change in DBP might result from the 
implementation of exercise components that lack efficacy (i.e. either of insufficient volume or 
intensity of effort).  
 Other outcomes included a variety of questionnaires relating to mental wellbeing, quality of 
life, and self-efficacy relating to exercise. Only three schemes examined SWEMWBS and though the 
improvement was statistically significant, initial analysis suggested that it was unclear as to whether 
the change was meaningful (2.99 pts [1.61 to 4.36], p < 0.0001, pδ = 0.422). Sensitivity analysis did 
reveal one influential scheme and removal of that scheme improved the estimated from meta-analysis 
(3.81 [2.73 to 4.89], p < 0.0001, pδ = 0.018). That scheme however was considerably larger than the 
other two included (n = 1,479 vs 107 and 39). Thus it is possible that the point estimate from this 
scheme is better representative of μ and indeed the 95%CIs are far narrower suggesting better 
precision of the estimate. Only one study to our knowledge has examined SWEMWBS specifically in 
response to exercise based intervention. Skinner et al [50]
 
reported a point estimate for change in 
SWEMWBS of 1.5 pts [-1.0 to 4.0] after a short four week supervised exercise intervention once a 
week in prostate cancer survivors. Malcolm et al [51] used the full WEMWBS and reported a change 
of 3 pts [0.0 to 6.0] and, though both measure subtly different components of mental wellbeing, 
considering the relationship between both the SWEMWBS and WEMWBS [52] it seems as though 
this reflects a similar sized effect. Recent large scale observational research [53] highlights that 
physical activity is significantly and meaningfully associated with mental health (1.49 fewer days of 
poor mental health in the past month). However, RCT evidence from ERSs [54] would initially appear 
less supportive of a role for physical activity and exercise in mental health, in this case depression, 
though recent analysis suggests that many studies and media portrayals of the role of physical activity 
and exercise are misrepresented.[55] Other studies have shown reductions in anxiety and depression 
from ERSs in both those with and without prior mental health issues.[22,56] Despite a lack of 
agreement within the extant literature it would appear that physical activity and exercise can have 
positive effects upon mental health. Indeed, recent work shows that resistance training for example 
improves both anxiety and depressive symptoms regardless of prior health status,[57,58] and meta-
analysis of broad exercise approaches for depression controlling for publication bias support an 
effect.[59] Our results suggest this effect may also be present in those undergoing ERSs, yet the 
clinical meaningfulness of the effect is less clear. 
 Global wellbeing and quality of life related outcomes were also explored in some ERS. One 
scheme collected the WHO-5 wellbeing-index where there was a statistically significant, yet likely 
not meaningful, change (8.78 pts [6.84 to 10.63], pδ = 0.834]. Few studies have used the WHO-5 as an 
outcome measure,[30] though one has compared exercise to wake therapy in those with major 
depression [60] reporting a point estimate for improvement from exercise of 46 pts.  A study in older 
adults performing a 6 months progressive high effort resistance training intervention [61] found an 
improvement of 7.26 pts [5.78 to 8.74]. It would seem that responsiveness of the WHO-5 to exercise 
based interventions may be at least in part dependent upon the population as large effects have been 
reported for major depression [60] whereas the effects reported for older adults,[61] and here in ERS 
participants, do not typically exceed the minimal clinically important change.[30] A relatively novel 
outcome measure designed specifically for evaluation of quality of life in those participating in ERSs 
[31] was also included in some schemes. Results from the meta-analysis suggested that there was a 
statistically significant improvement in this outcome (15.26 pts [4.71 to 25.82], p =0.0046), and that 
sensitivity analysis revealed an increase in the precision of estimate for the effect when one influential 
scheme was removed (9.83 pts [8.70 to 10.95], p < 0.001). However, though specifically designed for 
use with ERSs, this outcome lacks research regarding what constitutes a minimal clinically important 
change and so it is difficult to determine whether the improvements seen are indeed meaningful.  
 The final outcome examined, ESES, was only collected by one scheme. ESES showed a 
significant change of 2.58 pts [1.76 to 3.40], though the lack of prior literature examining this as an 
outcome measure makes it difficult to determine the meaningfulness of this change. Exercise 
interventions have been shown to improve general self-efficacy.[62] Further the extent to which self-
efficacy is affected by an intervention may impact upon their ability to produce behaviour change 
(e.g. for web based health interventions [63]). It has also been shown that changes towards higher 
exercise self-efficacy predicts continuation of exercise behaviour once an intervention has ended.[64] 
Thus it might be that the results here suggesting an impact of ERS upon ESES might lead to longer 
term maintenance of behaviour.  
As noted, currently there is a lack of agreement of what constitutes ‘impact’ with respect to 
the evaluation of ERS [41] and the evidence presented here from one of the largest databases of ERS 
does little to support the use of ERSs, broadly speaking. Though it should be noted that the database 
and analyses presented here are not without limitations (observational data without control group for 
counterfactual, follow-up bias due to high proportion of dropouts, selection of null intervals for 
meaningfulness of effects, details of specific components of ERS including fidelity, or consideration 
of participant characteristics such as referral reasons etc.) and these are detailed further in the 
accompanying manuscript describing the initial overview of the database.[27] Indeed, in considering 
factors such as lack of appropriate controls and follow up bias, it may be that the overall effects 
reported may be lesser in reality. However, given the considerable heterogeneity seen between 
schemes (I
2 
> 78% across outcomes) some schemes may be more effective than other due to 
characteristics either relating to the scheme specifically, or perhaps characteristics of the types of 
participants undergoing that scheme. Given that scheme level characteristics regarding delivery are 
not present available in this dataset, it is unfortunately difficult to explore the effects of personal level 
characteristics (e.g. BMI pre-ERS).  
 
Conclusion 
The data presented here represents the initial findings from first analysis of the National 
Referral Database health and wellbeing data. The analyses performed were with the intention of 
considering broadly “do we observe a meaningful effect in people who are undergoing ERSs?” and 
the findings revealed a general lack of meaningful change over time in participants undergoing ERSs 
lasting between six weeks to three months in length. These findings suggest the need to consider the 
implementation of ERSs more critically to discern how best to maximize their potential in light of the 
wider literature supporting the efficacy of physical activity and exercise, and the extensive reach of 
ERSs across the UK.  
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Table 1. Characteristics of all schemes included in analysis. 
Scheme Number Age (Mean±SD) N (% male) 
5001 56±17 1264 (41.6%) 
5002 48±12 3736 (24.7%) 
5026 49±13 2070 (22.9%) 
5036 51±15 3736 (27.9%) 
5056 50±15 4574 (34.2%) 
5063 45±11 325 (27.1%) 
5072 48±12 1735 (25.9%) 
5089 56±15 1670 (40.5%) 
5108 51±16 591 (30.0%) 
5115 57±14 853 (45.0%) 
5131 50±16 1628 (39.5%) 
5144 53±17 450 (39.8%) 
5156 59±15 1099 (38.1%) 
All schemes 51±15 23731 (31.8%) 
 
 
Table 2. Pre-ERS scores for all outcome measures for each scheme included in analysis. 
Scheme BMI (kg.m
2
) RHR (fc) SBP (mmHg) DBP 
(mmHg) 
WHO-5 (pts) SWEMWBS 
(pts) 
ERQoL (pts) ESES (pts) 
5001 27.90±5.66 72.70±9.32 127.80±15.09 78.91±9.54 N/A N/A N/A N/A 
5002 33.56±5.67 76.74±10.40 130.20±17.10 81.18±9.83 N/A 23.75±5.32 N/A N/A 
5026 30.95±6.23 77.33±11.50 129.00±16.73 79.75±9.40 N/A N/A N/A N/A 
5036 31.60±6.53 76.20±11.41 134.60±16.06 81.41±9.56 N/A N/A N/A N/A 
5056 30.78±6.00 76.13±10.96 130.50±17.72 77.76±10.42 N/A N/A N/A N/A 
5063 31.63±4.89 71.67±10.86 132.10±10.87 80.86±6.44 N/A 23.25±5.74 N/A N/A 
5072 35.13±6.80 68.54±8.49 134.20±16.88 81.35±9.80 N/A N/A N/A N/A 
5089 32.46±7.26 N/A 134.40±15.30 81.29±9.17 N/A N/A N/A N/A 
5108 30.63±6.66 71.90±10.42 131.30±18.63 83.39±9.17 N/A N/A 70.47±12.42 N/A 
5115 N/A N/A N/A N/A N/A 23.68±4.17 N/A N/A 
5131 25.64±4.11 N/A 126.00±16.34 78.21±9.43 40.86±20.70 N/A N/A 30.94±5.89 
5144 30.35±5.33 N/A 127.00±4.24 77.50±10.61 N/A N/A 74.49±12.44 N/A 
5156 N/A 76.55±9.43 134.1±16.38 79.68±9.37 N/A N/A 56.44±14.19 N/A 
All schemes 31.53±6.53 75.81±10.76 131.70±16.91 80.13±9.91 40.86±20.70 23.72±5.33 62..37±15.32 30.94±5.89 
Figure titles 
Figure 1. Forest plot of change in BMI across schemes. Note: dashed red lines represent the MCIC 
derived null intervals for interpretation of the meaningfulness of changes. 
 
Figure 2. Forest plot of change in RHR across schemes. Note: dashed red lines represent the MCIC 
derived null intervals for interpretation of the meaningfulness of changes. 
 
Figure 3. Forest plot of change in SBP across schemes. Note: dashed red lines represent the MCIC 
derived null intervals for interpretation of the meaningfulness of changes. 
 
Figure 4. Forest plot of change in DBP across schemes. Note: dashed red lines represent the MCIC 
derived null intervals for interpretation of the meaningfulness of changes. 
 
Figure 5. Forest plot of change in SWEMWBS across schemes. Note: dashed red line represents the 
MCIC derived null intervals for interpretation of the meaningfulness of changes. 
 
Figure 6. Forest plot of change in ERQoL across schemes. 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
